Maribess L. Miller
Known title: DirectorCIK: 0001488288
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
Triumph Financial downgraded as analysts call it overpriced. Triumph Financial was downgraded in a recent Seeking Alpha note that described the stock as overpriced even if economic conditions remain stable. The downgrade adds to a broader mixed view of financial stocks, with some benefiting from higher cash yields while many U.S. banks saw lower prices in September. The stock is trading near its long‑term support level, and its high trailing P/E suggests valuation concerns remain.
Transaction History
| DHI | ▲ Buy | Option Exercise | 139 | — | 4/20/2026 | View on chart |
| DHI | ▲ Buy | Option Exercise | 224 | — | 3/30/2026 | View on chart |
| DHI | ▲ Buy | Option Exercise | 93 | — | 3/21/2026 | View on chart |
| DHI | ▲ Buy | Option Exercise | 203 | — | 3/17/2026 | View on chart |
| DHI | ▲ Buy | Option Exercise | 289 | — | 11/20/2025 | View on chart |
| TFIN | ▲ Buy | Grant | 613 | $0 | 7/1/2025 | View on chart |
| DHI | ▲ Buy | Option Exercise | 139 | — | 4/21/2025 | View on chart |
| DHI | ▲ Buy | Option Exercise | 224 | — | 3/30/2025 | View on chart |
| DHI | ▲ Buy | Option Exercise | 93 | — | 3/21/2025 | View on chart |
| DHI | ▲ Buy | Option Exercise | 203 | — | 3/17/2025 | View on chart |
| DHI | ▲ Buy | Option Exercise | 449 | — | 3/12/2025 | View on chart |
| TFIN | ▲ Buy | Grant | 493 | $0 | 2/3/2025 | View on chart |
| DHI | ▲ Buy | Option Exercise | 1,748 | — | 1/26/2025 | View on chart |
| TFIN | ▼ Sell | Gift | 1,260 | $0 | 12/4/2024 | View on chart |
| DHI | ▲ Buy | Option Exercise | 1,000 | — | 11/7/2024 | View on chart |
| TFIN | ▲ Buy | Grant | 468 | $0 | 7/1/2024 | View on chart |
| DHI | ▲ Buy | Option Exercise | 139 | — | 4/20/2024 | View on chart |
| DHI | ▲ Buy | Option Exercise | 224 | — | 3/30/2024 | View on chart |
| DHI | ▲ Buy | Option Exercise | 203 | — | 3/17/2024 | View on chart |
| DHI | ▲ Buy | Option Exercise | 449 | — | 3/12/2024 | View on chart |
| TFIN | ▲ Buy | Grant | 538 | $0 | 2/1/2024 | View on chart |
| DHI | ▲ Buy | Option Exercise | 1,748 | — | 1/26/2024 | View on chart |
| DHI | ▼ Sell | Gift | 1,000 | $0 | 12/20/2023 | View on chart |
| DHI | ▲ Buy | Option Exercise | 1,000 | $0 | 11/7/2023 | View on chart |
| TFIN | ▲ Buy | Grant | 571 | $0 | 7/3/2023 | View on chart |
| DHI | ▲ Buy | Option Exercise | 224 | $0 | 3/30/2023 | View on chart |
| DHI | ▲ Buy | Option Exercise | 203 | $0 | 3/17/2023 | View on chart |
| DHI | ▲ Buy | Option Exercise | 449 | — | 3/12/2023 | View on chart |
| TFIN | ▲ Buy | Grant | 600 | $0 | 2/1/2023 | View on chart |
| DHI | ▲ Buy | Option Exercise | 1,748 | — | 1/26/2023 | View on chart |
| DHI | ▲ Buy | Option Exercise | 2,667 | — | 1/22/2023 | View on chart |
| DHI | ▲ Buy | Option Exercise | 1,000 | — | 11/7/2022 | View on chart |
| TFIN | ▲ Buy | Grant | 546 | $0 | 7/1/2022 | View on chart |
| DHI | ▲ Buy | Option Exercise | 203 | — | 3/17/2022 | View on chart |
| DHI | ▲ Buy | Option Exercise | 449 | — | 3/11/2022 | View on chart |
| TFIN | ▲ Buy | Grant | 399 | $0 | 2/1/2022 | View on chart |
| DHI | ▲ Buy | Option Exercise | 2,666 | — | 1/21/2022 | View on chart |
| DHI | ▲ Buy | Option Exercise | 1,000 | — | 11/5/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
D.R. Horton Analysts Update Coverage and Targets Amid Slower Sales
StoneX has begun coverage of D.R. Horton with a hold rating, joining Citigroup and RBC, which have both lowered their price targets to $150 and $119 respectively. Oppenheimer notes that slower home sales and margin pressure could weigh on the company’s earnings. With the stock near its $146.56 support level and a moderate RSI, the recent analyst updates add uncertainty to the near‑term outlook.
D.R. Horton Analysts Update Coverage and Targets Amid Slower Sales. StoneX has begun coverage of D.R. Horton with a hold rating, joining Citigroup and RBC, which have both lowered their price targets to $150 and $119 respectively. Oppenheimer notes that slower home sales and margin pressure could weigh on the company’s earnings. With the stock near its $146.56 support level and a moderate RSI, the recent analyst updates add uncertainty to the near‑term outlook.